查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1388187

等離子市場、份額、規模、趨勢、行業分析報告：按類型、按應用、按最終用途、按地區、按細分市場、預測，2023-2032年

Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris市場研究公司的最新研究，預計到2032年，全球等離子市場規模將達到547.8767億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

血漿市場正在經歷顯著成長，特別是由於血友病和地中海貧血等嚴重血液疾病的盛行率不斷上升，每年影響數百名新生兒。 血漿是血液的液體成分，在運輸各種血液成分方面發揮重要作用，A.B 型血的人尤其需要血漿。 血漿用於治療燒傷、休克、創傷和凝血障礙，並有助於增加血液容積、預防休克和凝血支持。 製藥公司使用血漿來製造治療出血性疾病和免疫缺陷的藥物。

市場擴張是由政府措施、社會意識增強、研發努力、醫療保健產業擴大、人口老化以及血漿衍生產品採用增加所推動的。 凝血因子 VIII 和免疫球蛋白等血漿衍生產品對於血液相關疾病的治療至關重要。 先進的血漿衍生產品研發、策略製造、技術進步、龐大的患者基礎和不斷增加的醫療保健支出都有助於市場在 2022-2032 年預測期內的積極成長。

血漿市場正面臨基因工程替代品的顛覆，這些替代品可以在不依賴人類血漿的情況下為各種醫療狀況提供治療。 生物工程蛋白質和凝血因子可以透過重組技術生產，減少對血漿的依賴。 這種競爭會影響定價和市場佔有率。 基因工程替代品被認為更安全，因為它們消除了某些疾病和病症中與血漿衍生產品相關的病原體傳播風險。

等離子市場報告亮點

2022年免疫球蛋白將佔銷售份額的45.4%，將在免疫反應以及自體免疫疾病和免疫缺陷疾病的治療中發揮重要作用。

免疫缺陷疾病細分市場佔 2022 年銷售額的 28.7%，主要依靠免疫球蛋白等血漿衍生產品來治療各種原發性免疫缺陷疾病。

到 2022 年，對於國際需求和公共衛生準備至關重要的血漿衍生產品的供應，北美將佔全球市場的 45.5% 份額。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章全球血漿市場洞察

  • Plasma - 行業概況
  • 血漿市場動態
    • 促進因素和機會
      • 對血漿衍生療法的需求不斷增加
      • 老年人口的增加推動市場成長
    • 抑制因素和挑戰
      • 高成本和重組替代品阻礙了市場成長
  • PESTEL 分析
  • 等離子市場的產業趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球等離子市場，依類型

  • 主要發現
  • 簡介
  • 白蛋白
  • 因子 VIII
  • 因子 IX
  • 免疫球蛋白
  • 超免疫球蛋白
  • 其他

第 6 章全球等離子體市場，依應用劃分

  • 主要發現
  • 簡介
  • 血友病
  • 低丙種球蛋白血症
  • 免疫缺乏疾病
  • 血管性血友病
  • 其他

第 7 章全球血漿市場，依最終用途劃分

  • 主要發現
  • 簡介
  • 醫院
  • 診所
  • 其他

第 8 章全球等離子市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年按地區劃分的血漿市場評估
  • 血漿市場 - 北美
    • 北美：血漿市場，按類型，2019-2032 年
    • 北美：血漿市場，依最終用途，2019-2032 年
    • 北美：血漿市場，依應用劃分，2019-2032 年
    • 血漿市場－美國
    • 血漿市場 - 加拿大
  • 血漿市場 - 歐洲
    • 歐洲：血漿市場，依類型，2019-2032 年
    • 歐洲：血漿市場，依最終用途，2019-2032 年
    • 歐洲：血漿市場，依應用劃分，2019-2032 年
    • 血漿市場 - 英國
    • 血漿市場 - 法國
    • 血漿市場 - 德國
    • 血漿市場 - 義大利
    • 血漿市場 - 西班牙
    • 等離子市場 - 荷蘭
    • 血漿市場 - 俄羅斯
  • 血漿市場 - 亞太地區
    • 亞太地區：血漿市場（按類型），2019-2032 年
    • 亞太地區：血漿市場，依最終用途，2019-2032 年
    • 亞太地區：血漿市場，依應用劃分，2019-2032 年
    • 血漿市場 - 中國
    • 血漿市場 - 印度
    • 血漿市場 - 馬來西亞
    • 血漿市場 - 日本
    • 血漿市場 - 印度尼西亞
    • 血漿市場－韓國
  • 血漿市場 - 中東和非洲
    • 中東和非洲：血漿市場（按類型），2019-2032 年
    • 中東和非洲：血漿市場，依最終用途，2019-2032 年
    • 中東和非洲：血漿市場，按應用劃分，2019-2032 年
    • 血漿市場 - 沙烏地阿拉伯
    • 血漿市場 - 阿拉伯聯合大公國
    • 血漿市場 - 以色列
    • 血漿市場 - 南非
  • 血漿市場 - 拉丁美洲
    • 拉丁美洲：血漿市場，依類型，2019-2032 年
    • 拉丁美洲：血漿市場，依最終用途，2019-2032 年
    • 拉丁美洲：血漿市場，按應用劃分，2019-2032 年
    • 血漿市場 - 墨西哥
    • 血漿市場 - 巴西
    • 血漿市場 - 阿根廷

第 9 章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 10 章公司簡介

  • Biotest AG
  • CSL
  • GC Biopharma Corp
  • Grifols
  • Intas Pharmaceuticals Ltd
  • Kedrion S.p.A.
  • LFB
  • Octapharma AG
  • Sanquin
  • Takeda Pharmaceuticals
Product Code: PM1311

The global blood plasma market size is expected to reach USD 54,787.67 million by 2032, according to a new study by Polaris market research. The report "Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others); By Application; By End-Use; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blood plasma market is experiencing substantial growth due to the increasing prevalence of severe blood disorders, notably Hemophilia and Thalassemia, impacting hundreds of newborns annually. Blood plasma, the fluid component of blood, plays a crucial role in transporting various blood constituents and is particularly in demand from individuals with blood type A.B. It is used in treating burn, shock, trauma, and clotting disorders, aiding in blood volume, shock prevention, and clotting support. Pharmaceutical companies utilize plasma for producing treatments for bleeding disorders and immune deficiencies.

The market's expansion is driven by government initiatives, growing public awareness, research and development efforts, healthcare sector expansion, an aging population, and increased adoption of plasma-derived products. Plasma-derived products like coagulation factor VIII and immunoglobulins are essential for managing blood-related disorders. Research and development in advanced plasma-derived products, strategic manufacturing, technological advancements, a substantial patient base, and increased healthcare expenditure all contribute to the market's positive trajectory during the 2022 to 2032 forecast period.

The blood plasma market faces disruption from recombinant alternatives that offer treatments for various medical conditions without relying on human plasma. Biologically engineered proteins and clotting factors can be produced through recombinant technologies, reducing dependence on plasma. This competition can impact pricing and market share, as recombinant alternatives are perceived as safer, eliminating the risk of pathogen transmission associated with plasma-derived products in specific diseases and medical conditions.

Blood Plasma Market Report Highlights

Immunoglobulins dominated with 45.4% revenue share in 2022, serving vital roles in immune responses and treating autoimmune and immunodeficiency disorders.

Immunodeficiency Diseases segment accounted for 28.7% of revenue in 2022, primarily relying on blood plasma-derived products, like immunoglobulins, to manage various primary immunodeficiency disorders.

North America led the 2022 global market 45.5% share in supplying plasma-derived products, vital for international demand and public health preparedness.

The global key market players include: Biotest AG, CSL, GC Biopharma Corp, Grifols, Intas Pharmaceuticals Ltd, Kedrion S.p.A., LFB, Octapharma AG, Sanquin, Takeda Pharmaceuticals

Polaris market research has segmented the Blood Plasma market report based on Type, Application, End-User, and region:

Blood Plasma, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Blood Plasma, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Hemophilia
  • Hypogammaglobinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Blood Plasma, End-User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Clinics
  • Others

Blood Plasma, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Blood Plasma Market Insights

  • 4.1. Blood Plasma - Industry Snapshot
  • 4.2. Blood Plasma Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Plasma-Derived Therapies
      • 4.2.1.2. Growing Geriatric Population Fuels the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost and Recombinant Alternatives Hampers the Growth of the Market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Blood Plasma Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Blood Plasma Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. Albumin
    • 5.3.1. Global Blood Plasma Market, by Albumin, by Region, 2019 - 2032 (USD Million)
  • 5.4. Factor VIII
    • 5.4.1. Global Blood Plasma Market, by Factor VIII, by Region, 2019 - 2032 (USD Million)
  • 5.5. Factor IX
    • 5.5.1. Global Blood Plasma Market, by Factor IX, by Region, 2019 - 2032 (USD Million)
  • 5.6. Immunoglobulin
    • 5.6.1. Global Blood Plasma Market, by Immunoglobulin, by Region, 2019 - 2032 (USD Million)
  • 5.7. Hyperimmune Globulin
    • 5.7.1. Global Blood Plasma Market, by Hyperimmune Globulin, by Region, 2019 - 2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Other Blood Plasma Market, by Region, 2019 - 2032 (USD Million)

6. Global Blood Plasma Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Hemophilia
    • 6.3.1. Global Blood Plasma Market, by Hemophilia, by Region, 2019 - 2032 (USD Million)
  • 6.4. Hypogammaglobulinemia
    • 6.4.1. Global Blood Plasma Market, by Hypogammaglobulinemia, by Region, 2019 - 2032 (USD Million)
  • 6.5. Immunodeficiency Diseases
    • 6.5.1. Global Blood Plasma Market, by Immunodeficiency Diseases, by Region, 2019 - 2032 (USD Million)
  • 6.6. Von Willebrand's Disease
    • 6.6.1. Global Blood Plasma Market, by Von Willebrand's Disease, by Region, 2019 - 2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Blood Plasma Market, by Other Applications, by Region, 2019 - 2032 (USD Million)

7. Global Blood Plasma Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Blood Plasma Market, by Hospitals, by Region, 2019 - 2032 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Global Blood Plasma Market, by Clinics, by Region, 2019 - 2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Other Blood Plasma Market, by Region, 2019 - 2032 (USD Million)

8. Global Blood Plasma Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Blood Plasma Market - North America
    • 8.3.1. North America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Blood Plasma Market - U.S.
      • 8.3.4.1. U.S.: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Blood Plasma Market - Canada
      • 8.3.5.1. Canada: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Blood Plasma Market - Europe
    • 8.4.1. Europe: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Blood Plasma Market - UK
      • 8.4.4.1. UK: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Blood Plasma Market - France
      • 8.4.5.1. France: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Blood Plasma Market - Germany
      • 8.4.6.1. Germany: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Blood Plasma Market - Italy
      • 8.4.7.1. Italy: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Blood Plasma Market - Spain
      • 8.4.8.1. Spain: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Blood Plasma Market - Netherlands
      • 8.4.9.1. Netherlands: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Blood Plasma Market - Russia
      • 8.4.10.1. Russia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Blood Plasma Market - Asia Pacific
    • 8.5.1. Asia Pacific: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Blood Plasma Market - China
      • 8.5.4.1. China: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Blood Plasma Market - India
      • 8.5.5.1. India: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Blood Plasma Market - Malaysia
      • 8.5.6.1. Malaysia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Blood Plasma Market - Japan
      • 8.5.7.1. Japan: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Blood Plasma Market - Indonesia
      • 8.5.8.1. Indonesia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Blood Plasma Market - South Korea
      • 8.5.9.1. South Korea: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Blood Plasma Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Blood Plasma Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Blood Plasma Market - UAE
      • 8.6.5.1. UAE: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Blood Plasma Market - Israel
      • 8.6.6.1. Israel: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Blood Plasma Market - South Africa
      • 8.6.7.1. South Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Blood Plasma Market - Latin America
    • 8.7.1. Latin America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Blood Plasma Market - Mexico
      • 8.7.4.1. Mexico: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Blood Plasma Market - Brazil
      • 8.7.5.1. Brazil: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Blood Plasma Market - Argentina
      • 8.7.6.1. Argentina: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biotest AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CSL
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. GC Biopharma Corp
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Grifols
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Intas Pharmaceuticals Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Kedrion S.p.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. LFB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Octapharma AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanquin
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Takeda Pharmaceuticals
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 2 Global Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 3 Global Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 4 Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Table 5 North America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 6 North America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 7 North America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 8 U.S.: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 9 U.S.: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 10 U.S.: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 11 Canada: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 12 Canada: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 13 Canada: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 14 Europe: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 15 Europe: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 16 Europe: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 17 UK: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 18 UK: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 19 UK: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 20 France: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 21 France: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 22 France: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 23 Germany: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 24 Germany: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 25 Germany: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 26 Italy: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 27 Italy: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 28 Italy: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 29 Spain: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 30 Spain: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 31 Spain: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 32 Netherlands: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 33 Netherlands: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 34 Netherlands: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 35 Russia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 36 Russia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 37 Russia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 38 Asia Pacific: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 39 Asia Pacific: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 40 Asia Pacific: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 41 China: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 42 China: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 43 China: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 44 India: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 45 India: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 46 India: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 47 Malaysia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 48 Malaysia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 49 Malaysia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 50 Japan: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 51 Japan: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 52 Japan: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 53 Indonesia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 54 Indonesia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 55 Indonesia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 56 South Korea: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 57 South Korea: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 58 South Korea: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 59 Middle East & Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 60 Middle East & Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 61 Middle East & Africa: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 62 Saudi Arabia: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 63 Saudi Arabia: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 64 Saudi Arabia: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 65 UAE: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 66 UAE: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 67 UAE: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 68 Israel: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 69 Israel: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 70 Israel: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 71 South Africa: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 72 South Africa: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 73 South Africa: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 74 Latin America: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 75 Latin America: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 76 Latin America: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 77 Mexico: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 78 Mexico: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 79 Mexico: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 80 Brazil: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 81 Brazil: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 82 Brazil: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)
  • Table 83 Argentina: Blood Plasma Market, by Type, 2019 - 2032 (USD Million)
  • Table 84 Argentina: Blood Plasma Market, by Application, 2019 - 2032 (USD Million)
  • Table 85 Argentina: Blood Plasma Market, by End-Use, 2019 - 2032 (USD Million)

List of Figures

  • Figure 1. Global Blood Plasma Market, 2019 - 2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Blood Plasma Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Blood Plasma Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global Blood Plasma Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 12. Blood Plasma Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Figure 13. Strategic Analysis - Blood Plasma Market